fda semaglutide warning november 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs Ivím Health Raises Alarm as

Adherence to the prescribed dose escalation schedule is crucialthe standard 16-week gradual increase from 0.25 mg to 2.4 mg allows your digestive system time to adapt and minimises the intensity of gastrointestinal side effects

It slows gastric emptying and digestion by relaxing stomach muscles

Endogenous GLP-1 regulates postprandial glycemia in humans: Relative contributions of insulin, glucagon, and gastric emptying

Headache: Infrequently reported, typically mild

But unlike the GLP-1 the body produces (which is quickly broken down by enzymes after its been released), semaglutide has been pharmacologically modified so that the hormone lasts longer in the body thereby making a person feel fuller for longer after meals